BTG International Limited (2005) Treatment of neurodegenerative conditions. WO2005/018632/A1.

Preview

PDF WO2005018632A1.pdf Download (3MB)

Abstract

A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of gamma-linolenic acid, dihomo-gamma-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-beta1 levels in the patient to therapeutic levels.

Item Type:	Patent
Additional Information:	Publication date: Mar 3, 2005 WO_2005_018632_A1 Application date: Aug 13, 2004 GB_2004003524_W
Uncontrolled Keywords:	Treatment of multiple sclerosis
Subjects:	Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:	Organisation
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/4330

Actions (login required)

View Item

Downloads